Raymond James Financial Inc Pds Biotechnology Corp Transaction History
Raymond James Financial Inc
- $258 Billion
- Q1 2025
A detailed history of Raymond James Financial Inc transactions in Pds Biotechnology Corp stock. As of the latest transaction made, Raymond James Financial Inc holds 13,965 shares of PDSB stock, worth $20,947. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,965
Previous 15,865
11.98%
Holding current value
$20,947
Previous $25,000
36.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding PDSB
# of Institutions
55Shares Held
8.24MCall Options Held
151KPut Options Held
1.2K-
Armistice Capital, LLC New York, NY4.42MShares$6.63 Million0.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.51MShares$2.27 Million0.0% of portfolio
-
Black Rock Inc. New York, NY487KShares$730,4500.0% of portfolio
-
Geode Capital Management, LLC Boston, MA438KShares$656,8210.0% of portfolio
-
Blair William & CO Chicago, IL257KShares$385,8000.0% of portfolio
About PDS Biotechnology Corp
- Ticker PDSB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,458,700
- Market Cap $42.7M
- Description
- PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...